J H Coleman, P E Hayes. Show Affiliations »
Abstract
Mesh： See more » Antiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useBasal Ganglia Diseases/chemically inducedBasal Ganglia Diseases/drug therapyBasal Ganglia Diseases/prevention & controlButyrophenones/adverse effectsChlorpromazine/adverse effectsDrug Therapy, CombinationHumansIatrogenic DiseaseParasympatholytics/therapeutic usePiperazines/adverse effectsPiperidines/adverse effectsPsychotic Disorders/drug therapyTime Factors
Substances： See more » Antiparkinson AgentsButyrophenonesParasympatholyticsPiperazinesPiperidinesChlorpromazine
Year: 1975 PMID： 1100334
Source DB: PubMed Journal: Dis Nerv Syst ISSN： 0012-3714